财务业绩概览 - 2025年第三季度营收为41亿美元，同比增长5.2% [1] - 季度每股收益为3.00美元，高于去年同期的2.84美元 [1] - 营收超出市场一致预期40.7亿美元，超出幅度为0.86% [1] - 每股收益超出市场一致预期2.96美元，超出幅度为1.35% [1] 细分业务收入表现 - 技术与分析解决方案业务收入为16.3亿美元，同比增长5%，但低于分析师平均预期的16.6亿美元 [4] - 研发解决方案业务收入为22.6亿美元，同比增长4.5%，高于分析师平均预期的22.3亿美元 [4] - 合同销售与医疗解决方案业务收入为2.09亿美元，同比大幅增长16.1%，远超分析师平均预期的1.8027亿美元 [4] 细分业务利润表现 - 技术与分析解决方案业务利润为3.7亿美元，低于分析师平均预期的4.1255亿美元 [4] - 研发解决方案业务利润为4.96亿美元，与分析师平均预期的4.959亿美元基本持平 [4] - 合同销售与医疗解决方案业务利润为1300万美元，远超分析师平均预期的84万美元 [4] 运营指标与市场表现 - 公司未完成订单量为324亿美元，略低于两位分析师平均预期的324.9亿美元 [4] - 过去一个月公司股价回报率为+20.3%，显著跑赢Zacks标普500综合指数+3.6%的涨幅 [3]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________________________ FORM 10-Q _________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35907 __ ...

2025年第三季度业绩表现 - 调整后每股收益为3美元 超出Zacks共识预期1.4% 同比增长5.6% [1] - 总营收达41亿美元 略超共识预期 同比增长5.2% [1] - 调整后税息折旧及摊销前利润为9.49亿美元 同比增长1.1% 超出公司预期 [4] 各业务部门收入情况 - 研发部门收入23亿美元 同比增长4.5% 按固定汇率计算增长3.4% 超出公司22亿美元的预期 [3] - 技术与分析部门收入16亿美元 同比增长5% 按固定汇率计算增长3.3% 未达到公司17亿美元的预期 [3] - 合同销售与医疗解决方案收入2.09亿美元 同比增长16.1% 按固定汇率计算增长13.9% 超出公司1.817亿美元的预期 [4] 财务状况与现金流 - 季度末现金及现金等价物为18亿美元 上一季度为20亿美元 [5] - 长期债务（扣除流动部分）为150亿美元 第二季度末为154亿美元 [5] - 经营活动产生的净现金为9.08亿美元 资本支出为1.36亿美元 季度自由现金流达7.72亿美元 [5] 2025年全年业绩指引 - 更新营收指引至161.5亿-162.5亿美元 中点162亿美元高于Zacks共识预期161.6亿美元 [6] - 更新每股收益指引至11.85-11.95美元 中点11.90美元高于共识预期11.86美元 [6] - 调整后税息折旧及摊销前利润指引更新为37.75亿-38.00亿美元 [7] 股价表现 - 过去六个月股价上涨44.9% 表现优于行业13.2%的增长率及Zacks标普500综合指数26.6%的涨幅 [2] 其他公司业绩摘要 - Waste Connections第三季度调整后每股收益1.44美元 超出共识预期4.4% 同比增长6.7% 营收25亿美元同比增长5.1% [8][10] - Equifax第三季度调整后每股收益2.04美元 超出共识预期5.7% 同比增长10.3% 营收15亿美元同比增长6.9% [11]

IQVIA (NYSE:IQV) Q3 2025 Earnings Call October 28, 2025 09:00 AM ET Company ParticipantsKerri Joseph - SVP, Investor Relations and TreasuryAri Bousbib - Chairman and CEOMike Fedock - SVP, Managing Planning and AnalysisRon Bruehlman - EVP and CFOConference Call ParticipantsMichael Cherny - AnalystDavid Windley - AnalystJustin Bowers - AnalystEric Coldwell - AnalystElizabeth Anderson - AnalystJeff Garro - AnalystShlomo Rosenbaum - AnalystNone - AnalystOperatorLadies and gentlemen, thank you for standing by. A ...

IQVIA (NYSE:IQV) Q3 2025 Earnings Call October 28, 2025 09:00 AM ET Company ParticipantsKerri Joseph - SVP, Investor Relations and TreasuryAri Bousbib - Chairman and CEOMike Fedock - SVP, Managing Planning and AnalysisRon Bruehlman - EVP and CFOConference Call ParticipantsMichael Cherny - AnalystDavid Windley - AnalystJustin Bowers - AnalystEric Coldwell - AnalystElizabeth Anderson - AnalystJeff Garro - AnalystShlomo Rosenbaum - AnalystOperatorLadies and gentlemen, thank you for standing by. At this time, I ...

IQVIA (NYSE:IQV) Q3 2025 Earnings Call October 28, 2025 09:00 AM ET Speaker4Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the IQVIA Third Quarter 2025 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would li ...

IQVIA Holdings (IQV) came out with quarterly earnings of $3 per share, beating the Zacks Consensus Estimate of $2.96 per share. This compares to earnings of $2.84 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +1.35%. A quarter ago, it was expected that this clinical testing company would post earnings of $2.76 per share when it actually produced earnings of $2.81, delivering a surprise of +1.81%.Over the last four quarters, ...

Q3 2025 Earnings Call October 28, 2025 IQVIA Template (V2.1.0) 100% 50% 75% 25% 1 Legal This presentation should be viewed in conjunction with IQVIA's Q3 2025 earnings call Safe Harbor Statement for Forward-Looking Statements 2 IQVIA Template (V2.1.0) 100% 50% 75% 25% This presentation contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, inc ...

公司财务展望 - 公司收窄年度利润预期 下调展望区间的上限 [1] - 预计来自制药客户的研发合同取消情况将持续 [1]

PresentationAt this time, it's my pleasure to hand over to Ingrid McMahon, Director of IR. Please go madam.Ladies and gentlemen, welcome to the SIG Q3 2025 Results Conference Call and Live Webcast. I am Sandra, the Chorus Call operator. [Operator Instructions] The conference must not be recorded for publication or broadcast.Ingrid McMahonDirector of Investor Relations Thank you, Sandra. Good morning, ladies and gentlemen, and thank you for joining us. I'm Ingrid McMahon, Director of Investor Relations. And ...